Virtu Financial LLC Vor Biopharma Inc. Transaction History

Virtu Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$1.0 - $2.2 $12,370 - $27,214	12,370 New	12,370 $12,000
Q2 2023 Jul 27, 2023	SELL	$3.09 - $5.33 $11,732 - $20,238	-3,797 Reduced 24.4%	11,765 $36,000
Q1 2023 May 01, 2023	BUY	$4.68 - $6.96 $72,830 - $108,311	15,562 New	15,562 $84,000
Q2 2022 Aug 09, 2022	BUY	$3.89 - $6.44 $47,660 - $78,902	12,252 New	12,252 $61,000

41.2M

9.3K

100

Ticker VOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,056,300
Market Cap $33.1M
Description
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.